A Vaccine Therapy for Canine Visceral Leishmaniasis Promoted Significant Improvement of Clinical and Immune Status with Reduction in Parasite Burden

Herein, we evaluated the treatment strategy employing a therapeutic heterologous vaccine composed of antigens of Leishmania braziliensis associated with MPL adjuvant (LBMPL vaccine) for visceral leishmaniasis (VL) in symptomatic dogs naturally infected by Leishmania infantum. Sixteen dogs received i...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Front Immunol
Auteurs principaux: Roatt, Bruno Mendes, Aguiar-Soares, Rodrigo Dian de Oliveira, Reis, Levi Eduardo Soares, Cardoso, Jamille Mirelle de Oliveira, Mathias, Fernando Augusto Siqueira, de Brito, Rory Cristiane Fortes, da Silva, Sydnei Magno, Gontijo, Nelder De Figueiredo, Ferreira, Sidney de Almeida, Valenzuela, Jesus G., Corrêa-Oliveira, Rodrigo, Giunchetti, Rodolfo Cordeiro, Reis, Alexandre Barbosa
Format: Artigo
Langue:Inglês
Publié: Frontiers Media S.A. 2017
Sujets:
Immunology
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5338076/
https://ncbi.nlm.nih.gov/pubmed/28321217
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00217
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires